Financial Snapshot

Revenue
$71.21B
TTM
Gross Margin
69.18%
TTM
Net Earnings
$7.874B
TTM
Current Assets
$30.08B
Q2 2024
Current Liabilities
$30.03B
Q2 2024
Current Ratio
100.17%
Q2 2024
Total Assets
$129.8B
Q2 2024
Total Liabilities
$57.07B
Q2 2024
Book Value
$72.69B
Q2 2024
Cash
$6.795B
Q2 2024
P/E
16.73
Nov 29, 2024 EST
Free Cash Flow
$4.138B
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Revenue $46.44B $45.39B $39.18B $37.37B $37.63B $35.68B $36.22B $34.70B $34.86B $34.11B $33.31B $35.96B $35.06B $32.04B $30.75B $28.82B $29.21B $29.49B $28.51B $15.04B $8.048B $7.448B $6.488B $5.963B $2.658B $1.937B $3.916B $3.605B $3.511B
YoY Change 2.32% 15.86% 4.83% -0.7% 5.48% -1.5% 4.4% -0.47% 2.2% 2.41% -7.37% 2.56% 9.44% 4.18% 6.7% -1.34% -0.96% 3.42% 89.54% 86.92% 8.06% 14.8% 8.8% 124.34% 37.22% -50.54% 8.63% 2.68%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Revenue $46.44B $45.39B $39.18B $37.37B $37.63B $35.68B $36.22B $34.70B $34.86B $34.11B $33.31B $35.96B $35.06B $32.04B $30.75B $28.82B $29.21B $29.49B $28.51B $15.04B $8.048B $7.448B $6.488B $5.963B $2.658B $1.937B $3.916B $3.605B $3.511B
Cost Of Revenue $14.24B $13.70B $12.26B $12.16B $11.98B $11.44B $11.61B $10.70B $10.92B $11.03B $10.99B $11.12B $10.90B $8.717B $7.880B $7.337B $7.571B $7.587B $7.566B $3.753B $1.428B $1.378B $1.253B $1.442B $769.0M $310.0M $1.287B $1.225B $1.232B
Gross Profit €32.21B €31.69B $26.92B $25.21B $25.65B $24.24B $24.61B $24.00B $23.94B $23.08B $22.32B $24.84B $24.16B $23.32B $22.87B $21.48B $21.64B $21.90B $20.95B $11.29B $6.620B $6.070B $5.235B $4.521B $1.889B $1.627B $2.629B $2.380B $2.279B
Gross Profit Margin 69.35% 69.83% 68.72% 67.46% 68.17% 67.95% 67.94% 69.16% 68.68% 67.67% 67.0% 69.08% 68.9% 72.79% 74.37% 74.54% 74.08% 74.27% 73.46% 75.05% 82.26% 81.5% 80.69% 75.82% 71.07% 84.0% 67.13% 66.02% 64.91%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Selling, General & Admin €10.69B €10.49B $9.457B $9.304B $9.777B $9.772B $10.07B $9.422B $9.330B $9.047B $8.544B $8.947B $8.536B $7.567B $7.325B $7.168B $7.554B $8.020B $8.250B $4.500B $2.477B $2.428B $2.306B $2.016B $883.0M $1.068B $1.555B $1.346B $1.284B
YoY Change 1.91% 10.94% 1.64% -4.84% 0.05% -2.98% 6.9% 0.99% 3.13% 5.89% -4.5% 4.81% 12.81% 3.3% 2.19% -5.11% -5.81% -2.79% 83.33% 81.67% 2.02% 5.29% 14.38% 128.31% -17.32% -31.32% 15.53% 4.83%
% of Gross Profit 33.2% 33.1% 35.13% 36.91% 38.11% 40.31% 40.93% 39.27% 38.97% 39.2% 38.29% 36.02% 35.34% 32.45% 32.03% 33.37% 34.91% 36.62% 39.39% 39.86% 37.42% 40.0% 44.05% 44.59% 46.74% 65.64% 59.15% 56.55% 56.34%
Research & Development €6.728B €6.706B $5.689B $5.528B $6.017B $5.890B $5.472B $5.156B $5.069B $4.812B $4.757B $4.922B $4.811B $4.401B $4.583B $4.575B $4.537B $4.430B $4.044B $7.455B $1.316B $1.218B $1.031B $945.0M $455.0M $562.0M $496.0M $473.0M
YoY Change 0.33% 17.88% 2.91% -8.13% 2.16% 7.64% 6.13% 1.72% 5.34% 1.16% -3.35% 2.31% 9.32% -3.97% 0.17% 0.84% 2.42% 9.55% -45.75% 466.49% 8.05% 18.14% 9.1% 107.69% 13.31% 4.86%
% of Gross Profit 20.89% 21.16% 21.13% 21.93% 23.46% 24.3% 22.24% 21.49% 21.17% 20.85% 21.32% 19.82% 19.92% 18.87% 20.04% 21.3% 20.97% 20.23% 19.31% 66.03% 19.88% 20.07% 19.69% 20.9% 24.09% 21.38% 20.84% 20.75%
Depreciation & Amortization $2.172B $3.420B $3.351B $3.671B $7.445B $4.279B $3.686B $3.301B $4.276B $2.924B $5.569B $4.907B $5.553B $5.129B $5.011B $5.985B $4.664B $6.113B $5.951B $2.518B $390.0M $379.0M $301.0M $241.0M $125.0M $63.00M $207.0M $185.0M $171.0M
YoY Change -36.49% 2.06% -8.72% -50.69% 73.99% 16.09% 11.66% -22.8% 46.24% -47.5% 13.49% -11.63% 8.27% 2.35% -16.27% 28.32% -23.7% 2.72% 136.34% 545.64% 2.9% 25.91% 24.9% 92.8% 98.41% -69.57% 11.89% 8.19%
% of Gross Profit 6.74% 10.79% 12.45% 14.56% 29.02% 17.65% 14.98% 13.76% 17.86% 12.67% 24.96% 19.76% 22.99% 22.0% 21.91% 27.86% 21.56% 27.91% 28.41% 22.3% 5.89% 6.24% 5.75% 5.33% 6.62% 3.87% 7.87% 7.77% 7.5%
Operating Expenses €17.42B €17.20B $18.56B $17.70B $18.64B $17.87B $17.57B $16.60B $16.76B $16.55B $15.52B $17.24B $16.64B $15.41B $15.05B $15.02B $15.53B $16.17B $16.12B $13.45B $3.682B $3.593B $3.204B $2.983B $1.382B $1.154B $2.117B $1.841B $1.757B
YoY Change 1.29% -7.33% 4.84% -5.01% 4.28% 1.74% 5.79% -0.91% 1.23% 6.63% -9.98% 3.62% 7.97% 2.41% 0.19% -3.26% -3.98% 0.36% 19.81% 265.29% 2.48% 12.14% 7.41% 115.85% 19.76% -45.49% 14.99% 4.78%
Operating Profit €14.79B €14.50B $8.361B $7.508B $7.017B $6.372B $7.043B $7.391B $7.186B $6.528B $6.793B $7.595B $7.514B $7.904B $7.818B $6.457B $6.106B $5.729B $4.832B -$2.160B $2.938B $2.477B $2.031B $1.538B $507.0M $473.0M $512.0M $539.0M $522.0M
YoY Change 2.01% 73.38% 11.36% 7.0% 10.12% -9.53% -4.71% 2.85% 10.08% -3.9% -10.56% 1.08% -4.93% 1.1% 21.08% 5.75% 6.58% 18.56% -323.7% -173.52% 18.61% 21.96% 32.05% 203.35% 7.19% -7.62% -5.01% 3.26%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Interest Expense -$815.0M -$140.0M -$289.0M $7.119B -$210.0M -$273.0M -$221.0M -$237.0M -$228.0M -$208.0M -$312.0M -$366.0M -$315.0M -$324.0M -$222.0M -$183.0M -$209.0M -$275.0M -$408.0M $42.00M $154.0M $96.00M $102.0M $18.00M -$3.000M -$19.00M -$64.00M -$56.00M -$54.00M
YoY Change 482.14% -51.56% -104.06% -3490.0% -23.08% 23.53% -6.75% 3.95% 9.62% -33.33% -14.75% 16.19% -2.78% 45.95% 21.31% -12.44% -24.0% -32.6% -1071.43% -72.73% 60.42% -5.88% 466.67% -700.0% -84.21% -70.31% 14.29% 3.7%
% of Operating Profit -5.51% -0.97% -3.46% 94.82% -2.99% -4.28% -3.14% -3.21% -3.17% -3.19% -4.59% -4.82% -4.19% -4.1% -2.84% -2.83% -3.42% -4.8% -8.44% 5.24% 3.88% 5.02% 1.17% -0.59% -4.02% -12.5% -10.39% -10.34%
Other Income/Expense, Net -$67.00M -$39.00M -$72.00M -$89.00M $2.000M -$52.00M -$619.0M -$103.0M -$189.0M -$191.0M -$94.00M -$97.00M -$38.00M -$78.00M -$49.00M $70.00M $195.0M $163.0M -$17.00M $1.000M -$11.00M $0.00 $0.00 $0.00 $1.000M -$110.0M -$129.0M -$134.0M
YoY Change 71.79% -45.83% -19.1% -4550.0% -103.85% -91.6% 500.97% -45.5% -1.05% 103.19% -3.09% 155.26% -51.28% 59.18% -170.0% -64.1% 19.63% -1058.82% -1800.0% -109.09% -100.0% -100.91% -14.73% -3.73%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Pretax Income $7.153B $10.42B $7.798B $13.78B $2.752B $4.405B $5.531B $5.675B $5.243B $5.731B $4.603B $5.877B $5.319B $5.599B $6.066B $4.162B $5.772B $4.748B $2.643B -$2.537B $3.117B $2.572B $2.414B $1.602B $506.0M $404.0M $339.0M $353.0M $335.0M
YoY Change -31.37% 33.65% -43.4% 400.65% -37.53% -20.36% -2.54% 8.24% -8.52% 24.51% -21.68% 10.49% -5.0% -7.7% 45.75% -27.89% 21.57% 79.64% -204.18% -181.39% 21.19% 6.55% 50.69% 216.6% 25.25% 19.17% -3.97% 5.37%
Income Tax $1.602B $2.006B $1.558B $1.807B $121.0M $481.0M $1.722B $1.325B $709.0M $1.171B $763.0M $1.134B $455.0M $1.242B $1.364B $682.0M $687.0M $800.0M $477.0M $819.0M $1.058B $746.0M $842.0M $611.0M $162.0M $108.0M $72.00M $109.0M $107.0M
% Of Pretax Income 22.4% 19.25% 19.98% 13.12% 4.4% 10.92% 31.13% 23.35% 13.52% 20.43% 16.58% 19.3% 8.55% 22.18% 22.49% 16.39% 11.9% 16.85% 18.05% 33.94% 29.0% 34.88% 38.14% 32.02% 26.73% 21.24% 30.88% 31.94%
Net Earnings €5.436B €8.484B $6.223B $12.29B $2.754B $4.306B $8.416B $4.709B $4.287B $4.390B $3.717B $4.967B $5.693B $5.467B $5.265B $3.851B $5.263B $4.006B $2.258B -$3.610B $2.076B $1.759B $1.585B $985.0M $342.0M $193.0M $293.0M $266.0M $240.0M
YoY Change -35.93% 36.33% -49.38% 346.41% -36.04% -48.84% 78.72% 9.84% -2.35% 18.11% -25.17% -12.75% 4.13% 3.84% 36.72% -26.83% 31.38% 77.41% -162.55% -273.89% 18.02% 10.98% 60.91% 188.01% 77.2% -34.13% 10.15% 10.83%
Net Earnings / Revenue 11.7% 18.69% 15.89% 32.9% 7.32% 12.07% 23.24% 13.57% 12.3% 12.87% 11.16% 13.81% 16.24% 17.07% 17.12% 13.36% 18.02% 13.58% 7.92% -24.0% 25.8% 23.62% 24.43% 16.52% 12.87% 9.96% 7.48% 7.38% 6.84%
Basic Earnings Per Share
Diluted Earnings Per Share $4.31 $6.66 $4.947M $9.756M $2.191M $3.431M $6.644M $3.633M $3.246M $3.298M $2.776M $3.754M $4.290M $4.180M $4.028M $2.937M $3.887M $2.948M $1.676M -$3.911M $3.040M $2.506M $2.198M $1.364M $467.9K $4.021M $2.764M $2.558M $2.376M

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Cash & Short-Term Investments $8.710B $13.40B $11.15B $14.82B $9.853B $7.124B $10.32B $10.30B $9.259B $7.559B $8.442B $6.559B $4.297B $6.516B $4.969B $4.629B $1.794B $1.261B $1.560B $2.490B $3.378B $3.088B $4.289B $2.879B $2.356B $140.0M $776.0M $651.0M $596.0M
YoY Change -35.0% 20.16% -24.72% 50.36% 38.31% -30.94% 0.11% 11.29% 22.49% -10.46% 28.71% 52.64% -34.05% 31.13% 7.34% 158.03% 42.27% -19.17% -37.35% -26.29% 9.39% -28.0% 48.98% 22.2% 1582.86% -81.96% 19.2% 9.23%
Cash & Equivalents $8.710B $11.35B $8.740B $12.77B $8.726B $6.264B $10.32B $9.196B $7.787B $5.498B $7.304B $5.477B $3.095B $5.769B $4.003B $3.724B $880.0M $1.153B $1.249B $1.532B $152.0M $144.0M $123.0M $207.0M $202.0M $74.00M $110.0M $119.0M $108.0M
Short-Term Investments $664.0M $1.054B $900.0M $426.0M $199.0M $31.00M $111.0M $218.0M $185.0M $178.0M $173.0M $51.00M $277.0M $403.0M $83.00M $108.0M $311.0M $958.0M $3.226B $2.944B $4.166B $2.672B $2.154B $66.00M $666.0M $532.0M $488.0M
Other Short-Term Assets $920.0M $910.0M $583.0M $681.0M $633.0M $2.005B $441.0M $300.0M $296.0M $264.0M $258.0M $256.0M $186.0M $171.0M $173.0M $187.0M $164.0M $877.0M $2.193B $536.0M $541.0M $514.0M $445.0M $830.0M $420.0M $343.0M $376.0M
YoY Change 1.1% 56.09% -14.39% 7.58% -68.43% 354.65% 47.0% 1.35% 12.12% 2.33% 0.78% 37.63% 8.77% -1.16% -7.49% 14.02% -81.3% -60.01% 309.14% -0.92% 5.25% 15.51% -46.39% 22.45% -8.78%
Inventory $21.55B $8.960B $8.715B $8.352B $7.994B $7.477B $6.818B $6.896B $6.516B $6.562B $6.352B $6.379B $6.051B $5.020B $4.444B $3.590B $3.729B $3.659B $3.430B $3.058B $799.0M $823.0M $805.0M $737.0M $764.0M $194.0M $560.0M $495.0M $470.0M
Prepaid Expenses
Receivables $8.424B $7.568B $7.491B $7.937B $7.260B $7.216B $7.311B $7.386B $7.149B $6.831B $7.507B $8.042B $6.507B $6.015B $5.303B $4.904B $5.032B $5.021B $4.501B $1.491B $1.311B $1.566B $1.234B $1.099B $393.0M $920.0M $871.0M $802.0M
Other Receivables $2.322B $2.219B $2.462B $2.146B $2.085B $0.00 $1.739B $1.467B $1.861B $2.023B $2.097B $2.145B $1.814B $1.933B $1.708B $1.939B $2.044B $2.233B $2.208B $833.0M $797.0M $497.0M $505.0M $0.00 $174.0M $0.00 $0.00 $0.00
Total Short-Term Assets $30.66B $34.03B $30.56B $33.70B $28.61B $24.58B $26.35B $26.69B $300.0M $296.0M $23.91B $22.80B $20.79B $20.04B $17.53B $15.40B $12.55B $12.16B $13.12B $14.45B $7.037B $6.560B $7.671B $5.800B $5.049B $901.0M $2.675B $2.360B $2.244B
YoY Change -9.91% 11.33% -9.31% 17.8% 16.4% -6.74% -1.26% 8797.0% 1.35% -98.76% 4.88% 9.66% 3.73% 14.32% 13.82% 22.7% 3.23% -7.32% -9.2% 105.34% 7.27% -14.48% 32.26% 14.87% 460.38% -66.32% 13.35% 5.17%
Property, Plant & Equipment $11.81B $11.68B $11.98B $10.56B $11.02B $9.651B $9.579B $10.02B $9.943B $10.40B $10.18B $10.58B $10.75B $8.155B $7.830B $6.961B $6.538B $6.219B $6.184B $5.886B $1.449B $1.395B $1.229B $1.217B $1.143B $282.0M $699.0M $674.0M $612.0M
YoY Change 1.11% -2.44% 13.38% -4.12% 14.15% 0.75% -4.39% 0.76% -4.36% 2.1% -3.74% -1.6% 31.82% 4.15% 12.48% 6.47% 5.13% 0.57% 5.06% 306.21% 3.87% 13.51% 0.99% 6.47% 305.32% -59.66% 3.71% 10.13%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $10.07B $2.765B $2.425B $2.129B $5.303B $5.550B $5.428B $4.906B $4.681B $4.189B $5.274B $4.286B $3.206B $2.568B $1.953B $3.280B $3.530B $3.682B $3.795B $3.344B $242.0M $209.0M $258.0M $427.0M $371.0M $46.00M $444.0M $409.0M $413.0M
YoY Change 264.16% 14.02% 13.9% -59.85% -4.45% 2.25% 10.64% 4.81% 11.75% -20.57% 23.05% 33.69% 24.84% 31.49% -40.46% -7.08% -4.13% -2.98% 13.49% 1281.82% 15.79% -18.99% -39.58% 15.09% 706.52% -89.64% 8.56% -0.97%
Other Assets $203.0M $6.263B $5.329B $4.776B $6.150B $4.758B $4.378B $11.12B $10.52B $4.929B $4.168B $4.478B $3.700B $10.09B $9.254B $2.920B $2.912B $3.492B $3.095B $2.234B $30.00M
YoY Change -96.76% 17.53% 11.58% -22.34% 29.26% 8.68% -60.63% 5.76% 113.33% 18.26% -6.92% 21.03% -63.32% 9.0% 216.92% 0.27% -16.61% 12.83% 38.54%
Total Long-Term Assets $95.66B $92.70B $89.68B $80.71B $84.02B $86.83B $73.46B $77.99B $102.0B $97.10B $72.15B $77.61B $79.37B $65.22B $62.52B $56.58B $59.36B $65.60B $73.54B $62.31B $2.712B $2.899B $2.296B $2.045B $1.775B $968.0M $3.404B $3.228B $2.924B
YoY Change 3.2% 3.37% 11.11% -3.94% -3.24% 18.2% -5.81% -23.56% 5.07% 34.57% -7.03% -2.23% 21.7% 4.33% 10.49% -4.68% -9.51% -10.79% 18.03% 2197.38% -6.45% 26.26% 12.27% 15.21% 83.37% -71.56% 5.45% 10.4%
Total Assets $126.3B $126.7B $120.2B $114.4B $112.6B $111.4B $99.81B $104.7B $102.3B $97.39B $96.07B $100.4B $100.2B $85.26B $80.05B $71.99B $71.91B $77.76B $86.66B $76.76B $9.749B $9.459B $9.967B $7.845B $6.824B $1.869B $6.079B $5.588B $5.168B
YoY Change
Accounts Payable $20.88B $6.813B $6.180B $5.295B $5.313B $5.041B $4.633B $4.297B $3.817B $3.651B $3.003B $3.190B $3.183B $2.800B $2.654B $2.791B $2.749B $3.008B $3.193B $2.765B $657.0M $596.0M $717.0M $667.0M $642.0M $217.0M $440.0M $362.0M $355.0M
YoY Change 206.5% 10.24% 16.71% -0.34% 5.4% 8.81% 7.82% 12.58% 4.55% 21.58% -5.86% 0.22% 13.68% 5.5% -4.91% 1.53% -8.61% -5.79% 15.48% 320.85% 10.23% -16.88% 7.5% 3.89% 195.85% -50.68% 21.55% 1.97%
Accrued Expenses $2.158B $2.126B $2.042B $1.978B $1.989B $1.967B $1.920B $1.912B $1.839B $1.909B $1.957B $1.411B $1.458B $1.366B $1.337B $1.490B $1.292B $424.0M $384.0M $418.0M $352.0M
YoY Change 1.51% 4.11% 3.24% -0.55% 2.45% 0.42% 3.97% -3.67% -2.45% 38.7% -3.22% 6.73% 2.17% 15.33% 204.72% 10.42% -8.13% 18.75%
Deferred Revenue
YoY Change
Short-Term Debt $168.0M $189.0M $285.0M $305.0M $249.0M $237.0M $203.0M $228.0M $0.00 $0.00 $254.0M $977.0M $1.008B $317.0M $1.034B $545.0M $993.0M $2.348B $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $352.0M $307.0M $246.0M
YoY Change -11.11% -33.68% -6.56% 22.49% 5.06% 16.75% -10.96% -100.0% -74.0% -3.08% 217.98% -69.34% 89.72% -45.12% -57.71% -100.0% 14.66% 24.8%
Long-Term Debt Due $2.320B $4.287B $3.263B $2.714B $4.508B $2.364B $1.038B $1.561B $3.194B $858.0M $3.124B $3.558B $1.963B $557.0M $2.549B $799.0M $1.662B $1.452B $6.425B $7.388B $315.0M $351.0M $285.0M $291.0M $324.0M $47.00M $5.000M $21.00M $41.00M
YoY Change -45.88% 31.38% 20.23% -39.8% 90.69% 127.75% -33.5% -51.13% 272.26% -72.54% -12.2% 81.25% 252.42% -78.15% 219.02% -51.93% 14.46% -77.4% -13.03% 2245.4% -10.26% 23.16% -2.06% -10.19% 589.36% 840.0% -76.19% -48.78%
Total Short-Term Liabilities $24.01B $23.96B $21.30B $19.25B $20.38B $17.38B $15.46B $16.44B $1.920B $1.912B $13.96B $13.86B $13.56B $10.09B $10.97B $9.345B $9.669B $10.28B $15.16B $26.40B $2.601B $2.556B $3.006B $2.262B $2.230B $585.0M $1.507B $1.352B $1.231B
YoY Change 0.18% 12.53% 10.63% -5.56% 17.29% 12.37% -5.96% 756.41% 0.42% -86.3% 0.7% 2.18% 34.47% -8.01% 17.34% -3.35% -5.93% -32.21% -42.57% 914.99% 1.76% -14.97% 32.89% 1.43% 281.2% -61.18% 11.46% 9.83%
Long-Term Debt $16.10B $17.05B $19.02B $20.73B $21.17B $22.07B $14.31B $16.77B $13.02B $13.28B $10.41B $10.72B $12.50B $6.695B $5.961B $4.173B $3.734B $4.499B $4.750B $8.638B $53.00M $65.00M $119.0M $121.0M $137.0M $61.00M $645.0M $681.0M $677.0M
YoY Change -5.54% -10.35% -8.25% -2.09% -4.09% 54.25% -14.65% 28.73% -1.91% 27.48% -2.85% -14.24% 86.69% 12.31% 42.85% 11.76% -17.0% -5.28% -45.01% 16198.11% -18.46% -45.38% -1.65% -11.68% 124.59% -90.54% -5.29% 0.59%
Other Long-Term Liabilities $9.995B $8.718B $9.284B $9.418B $9.557B $9.512B $10.20B $11.46B $11.37B $10.71B $9.620B $12.42B $11.70B $11.39B $9.744B $7.730B $6.857B $7.920B $7.713B $5.784B $754.0M $786.0M $1.053B $1.130B $846.0M $110.0M $402.0M $368.0M $345.0M
YoY Change 14.65% -6.1% -1.42% -1.45% 0.47% -6.72% -11.0% 0.78% 6.13% 11.34% -22.57% 6.17% 2.78% 16.85% 26.05% 12.73% -13.42% 2.68% 33.35% 667.11% -4.07% -25.36% -6.81% 33.57% 669.09% -72.64% 9.24% 6.67%
Total Long-Term Liabilities $26.10B $25.77B $28.30B $30.14B $30.73B $31.58B $24.51B $28.22B $24.39B $23.99B $20.03B $23.14B $24.20B $18.08B $15.71B $11.90B $10.59B $12.42B $12.46B $14.42B $807.0M $851.0M $1.172B $1.251B $983.0M $171.0M $1.047B $1.049B $1.022B
YoY Change 1.29% -8.95% -6.12% -1.89% -2.72% 28.88% -13.17% 15.71% 1.68% 19.73% -13.43% -4.37% 33.85% 15.13% 31.94% 12.39% -14.72% -0.35% -13.58% 1687.11% -5.17% -27.39% -6.31% 27.26% 474.85% -83.67% -0.19% 2.64%
Total Liabilities $52.27B $51.94B $51.56B $51.31B $53.57B $52.53B $41.74B $47.13B $44.27B $41.27B $39.18B $43.07B $43.95B $32.17B $31.86B $27.12B $27.37B $32.16B $40.02B $41.18B $3.426B $3.424B $4.199B $3.541B $3.246B $774.0M $2.622B $2.485B $2.363B
YoY Change 0.65% 0.73% 0.5% -4.23% 1.98% 25.85% -11.42% 6.45% 7.27% 5.34% -9.03% -2.0% 36.62% 0.96% 17.48% -0.92% -14.9% -19.63% -2.82% 1102.01% 0.06% -18.46% 18.58% 9.09% 319.38% -70.48% 5.51% 5.16%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $131.76 Billion

About Sanofi

Sanofi engages in the research, production, and distribution of pharmaceutical products. The company is headquartered in Paris, Ile-De-France and currently employs 87,994 full-time employees. The company went IPO on 2002-07-01. The firm focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.

Industry: Pharmaceutical Preparations Peers: